LCN2 and breast cancer: TAMs in more aggressive forms of breast cancer secrete lipocalin 2 (Lcn2), a small molecule that increases iron concentration and the iron labile pool of cancer cells within the TME to promote growth and resistance to chemotherapy (50, 51).